JPH07203863A - Method for producing milk whey-derived β-lactoglobulin, α-lactalbumin and lactoferrin - Google Patents
Method for producing milk whey-derived β-lactoglobulin, α-lactalbumin and lactoferrinInfo
- Publication number
- JPH07203863A JPH07203863A JP1496494A JP1496494A JPH07203863A JP H07203863 A JPH07203863 A JP H07203863A JP 1496494 A JP1496494 A JP 1496494A JP 1496494 A JP1496494 A JP 1496494A JP H07203863 A JPH07203863 A JP H07203863A
- Authority
- JP
- Japan
- Prior art keywords
- whey
- nacl
- milk whey
- lactalbumin
- lactoferrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010046377 Whey Proteins Proteins 0.000 title claims abstract description 34
- 102000007544 Whey Proteins Human genes 0.000 title claims abstract description 33
- 239000005862 Whey Substances 0.000 title claims abstract description 31
- 235000013336 milk Nutrition 0.000 title claims abstract description 17
- 239000008267 milk Substances 0.000 title claims abstract description 17
- 210000004080 milk Anatomy 0.000 title claims abstract description 17
- 102000004407 Lactalbumin Human genes 0.000 title claims abstract description 7
- 108090000942 Lactalbumin Proteins 0.000 title claims abstract description 7
- 102000010445 Lactoferrin Human genes 0.000 title claims abstract description 6
- 108010063045 Lactoferrin Proteins 0.000 title claims abstract description 6
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title claims abstract description 6
- 235000021242 lactoferrin Nutrition 0.000 title claims abstract description 6
- 229940078795 lactoferrin Drugs 0.000 title claims abstract description 6
- 235000021241 α-lactalbumin Nutrition 0.000 title claims abstract description 6
- 102000008192 Lactoglobulins Human genes 0.000 title claims abstract description 5
- 108010060630 Lactoglobulins Proteins 0.000 title claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000018102 proteins Nutrition 0.000 claims abstract description 22
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 239000011780 sodium chloride Substances 0.000 claims abstract description 22
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 14
- 239000012539 chromatography resin Substances 0.000 claims abstract description 13
- 238000005194 fractionation Methods 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 19
- 239000011347 resin Substances 0.000 abstract description 4
- 229920005989 resin Polymers 0.000 abstract description 4
- 238000000108 ultra-filtration Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 7
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241001146155 Emilia Species 0.000 description 1
- 235000002139 Emilia sonchifolia Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000002031 ethanolic fraction Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
(57)【要約】
【目的】 牛乳ホエ−由来のβ−ラクトグロブリン(以
下β−Lgとする)、α−ラクトアルブミン(以下α−
Laとする)及びラクトフェリン(以下Lfとする)の
製造法に関し、更に詳細には、牛乳ホエ−中のβ−L
g、α−La及びLfを疎水クロマトグラフィ−樹脂と
接触させることにより分画する方法に関する。
【構成】 牛乳ホエ−をpH4.4〜4.6、蛋白質濃
度0.5〜10%、NaCl濃度1.0Mに調整して、
疎水クロマトグラフィ−樹脂に接触させ、0.75M
NaCl及び40%(V/V)エタノ−ルで分画する
か、牛乳ホエ−をpH3.0、蛋白質濃度0.5〜10
%、NaCl濃度0.5Mに調整して、疎水クロマトグ
ラフィ−樹脂に接触させ、0.75M NaCl及び4
0%(V/V)エタノ−ルで分画する。(57) [Summary] [Purpose] Milk whey-derived β-lactoglobulin (hereinafter referred to as β-Lg), α-lactalbumin (hereinafter referred to as α-lactalbumin).
La) and lactoferrin (hereinafter referred to as Lf), and more specifically, β-L in milk whey.
It relates to a method of fractionating g, α-La and Lf by contacting them with a hydrophobic chromatography resin. [Structure] Milk whey was adjusted to pH 4.4 to 4.6, protein concentration 0.5 to 10%, and NaCl concentration 1.0M,
Hydrophobic chromatography-contact with resin, 0.75M
Fractionation with NaCl and 40% (V / V) ethanol or milk whey pH 3.0, protein concentration 0.5-10
%, Adjusted to a NaCl concentration of 0.5 M and contacted with hydrophobic chromatography-resin, 0.75 M NaCl and 4
Fraction with 0% (V / V) ethanol.
Description
【0001】[0001]
【産業上の利用分野】この発明は牛乳ホエ−由来のβ−
ラクトグロブリン(以下β−Lgとする)、α−ラクト
アルブミン(以下α−Laとする)及びラクトフェリン
(以下Lfとする)の製造法に関し、更に詳細には、牛
乳ホエ−中のβ−Lg、α−La及びLfを疎水クロマ
トグラフィ−樹脂と接触させることにより分画する方法
に関するものである。This invention relates to β-derived from milk whey.
Regarding a method for producing lactoglobulin (hereinafter referred to as β-Lg), α-lactalbumin (hereinafter referred to as α-La) and lactoferrin (hereinafter referred to as Lf), more specifically, β-Lg in milk whey, The present invention relates to a method for fractionating α-La and Lf by bringing them into contact with a hydrophobic chromatography resin.
【0002】[0002]
【従来の技術】ホエ−は高い栄養価値と性質を有する多
くの蛋白質を含んでいることから、個々の蛋白質を単離
する方法は数多く報告されている。それらは各蛋白質の
理化学的性状を利用する方法と、分子量を利用する方法
に大別できる。それらの代表的な方法として、前者は塩
化鉄をホエ−に添加し、pHを3.0に調整してβ−L
g以外の蛋白質を沈殿させ分画する方法(クワタらJ.
Food Sci.,vol.50,No.3,605
〜609,1985)、β−Lgが二量体を形成し易い
と言う固有の特性を利用して、固定化β−Lgを用いて
β−Lgを特異的に単離する方法(チアンコネ・エミリ
ア、ガツトニ・マルジオ、特開昭64−63598号公
報)、CMCなどの高分子多荷電解質を用いてβ−Lg
を共沈させる方法(ジエ−・ヒダルゴら、J.Dair
y Sci.,54.1270,1970)及び各蛋白
質の電荷の差異を利用するイオン交換クロマトグラフイ
−法(Paul J.Skudder,Chemist
ry and Industry J.,7,810,
1983)などがあり、後者にはゲル濾過法や限外濾過
法(Lee and Merson, J.Food
Sci.,41,402〜410)が提案されている。BACKGROUND OF THE INVENTION Since whey contains many proteins having high nutritional value and properties, many methods for isolating individual proteins have been reported. They can be roughly classified into a method utilizing the physicochemical properties of each protein and a method utilizing the molecular weight. As a typical method of them, the former method is to add iron chloride to the whey and adjust the pH to 3.0 to obtain β-L.
Method of precipitating and fractionating proteins other than g (Kuwata et al.
Food Sci. , Vol. 50, No. 3,605
~ 609, 1985), a method of specifically isolating β-Lg using immobilized β-Lg by utilizing the unique property that β-Lg easily forms a dimer (Tiancone Emilia). , Gattoni Margio, JP-A-64-63598), and β-Lg using a polymer heavy electrolyte such as CMC.
Coprecipitation (Jie Hidalgo et al., J. Dair
y Sci. , 54.1270, 1970) and the ion-exchange chromatographic method (Paul J. Skudder, Chemist), which utilizes the difference in charge of each protein.
ry and Industry J. , 7, 810,
1983), and the latter includes gel filtration and ultrafiltration (Lee and Merson, J. Food).
Sci. , 41, 402-410) have been proposed.
【0003】上記各方法はそれぞれ長所を有するが、い
ずれも工程の煩雑性、エネルギ−コスト、著しい低収
率、多量の塩類の使用等の理由により、目的とする蛋白
質以外の各蛋白質が非可逆的に変性を受けており、ホエ
−の各蛋白質を工業的に高収率で得ようと試みた場合、
実行可能な方法にまで規模を拡大することはできていな
い。Although each of the above methods has its advantages, each of them is irreversible with the exception of the protein of interest due to the complexity of the process, energy cost, extremely low yield, use of a large amount of salts and the like. When it is attempted to industrially obtain each protein of whey in a high yield,
It has not been scaled to a viable way.
【0004】[0004]
【発明が解決しようとする課題】その最終製品を各蛋白
質の有する機能的特性を有した状態で食品工業の製品に
用いようとした場合、各蛋白質を夾雑物が少なく天然の
ままの物性、すなわち未変性で機能的特性が損なわれて
いない状態で、かつ高蛋白質含量の製品を得ることが必
須である。この発明はホエ−蛋白質の中でもとくにその
特性から非可逆的な変性を防止しなければならないβ−
Lg、α−La及びLfをそれらの蛋白質の疎水性の差
異を利用し、かつ一部従来技術を導入することにより、
高純度でほとんど変性させることなく上記の各蛋白質を
一連の操作により効率的に製造することにある。When the final product is to be used in a product of the food industry while having the functional properties of each protein, each protein has few contaminants, that is, its physical properties are as natural. It is essential to obtain a product with a high protein content, in a non-denatured state with functional properties intact. Among the whey proteins, this invention must prevent β-irreversible denaturation due to its properties.
By utilizing Lg, α-La and Lf by utilizing the difference in hydrophobicity of these proteins, and introducing some conventional techniques,
It is intended to efficiently produce each of the above proteins by a series of operations with high purity and without denaturation.
【0005】[0005]
【課題を解決するための手段】請求項1記載の発明で
は、牛乳ホエ−をpH4.4〜4.6、蛋白質濃度0.
5〜10%、NaCl濃度1.0Mに調整して、疎水ク
ロマトグラフィ−樹脂に接触させ、0.75M NaC
l及び40%(V/V)エタノ−ルで分画することを特
徴とする。According to a first aspect of the present invention, milk whey has a pH of 4.4 to 4.6 and a protein concentration of 0.
Adjusted to 5-10%, NaCl concentration 1.0M, contact with hydrophobic chromatography-resin, 0.75M NaCl
It is characterized by fractionation with 1 and 40% (V / V) ethanol.
【0006】請求項2記載の発明では、牛乳ホエ−をp
H3.0、蛋白質濃度0.5〜10%、NaCl濃度
0.5Mに調整して、疎水クロマトグラフィ−樹脂に接
触させ、0.75M NaCl及び40%(V/V)エ
タノ−ルで分画することを特徴とする。According to the second aspect of the invention, milk whey is added to the p
Adjust to H3.0, protein concentration 0.5-10%, NaCl concentration 0.5M, contact with hydrophobic chromatography resin and fractionate with 0.75M NaCl and 40% (V / V) ethanol. It is characterized by
【0007】請求項3記載の発明では、牛乳ホエ−が酸
ホエ−、甘性ホエ−及びそれらの濃縮等の加工されたホ
エ−から選ばれた一種又はそれ以上である請求項1又は
2記載の方法に関する。In the invention of claim 3, the milk whey is one or more selected from acid whey, sweet whey, and processed whey such as concentrated whey. Regarding the method.
【0008】[0008]
【作用】この発明の各種の牛乳ホエ−からβ−Lg、α
−La及びLfを効率的に分画する方法は、分子量、等
電点の近似しているβ−Lgとα−Laを分別するため
に、出発材料であるホエ−にNaClを加え、β−Lg
以外の蛋白質を疎水クロマトグラフィ−樹脂に吸着させ
ることにより、ホエ−蛋白質の約50%を占めるβ−L
gとその他の蛋白質を最初に分別し、次いで樹脂に吸着
したα−LaやLfなどを溶出し、限外濾過法で分画す
れば操作条件も非常に穏やかであり、従来技術でみられ
たような最終製品の非可逆的変性も生ぜず、かつ各蛋白
質を一連の操作工程で効率的に生産可能である。From various milk whey of the present invention, β-Lg, α
-To efficiently fractionate La and Lf, in order to separate β-Lg and α-La having similar molecular weights and isoelectric points, NaCl is added to the starting material, whey, and β-Lg is added. Lg
By adsorbing proteins other than the above to the hydrophobic chromatography resin, β-L occupying about 50% of the whey protein
g and other proteins were first fractionated, then α-La and Lf adsorbed on the resin were eluted and fractionated by the ultrafiltration method, the operating conditions were very gentle and found in the prior art. Such irreversible denaturation of the final product does not occur, and each protein can be efficiently produced by a series of operation steps.
【0009】[0009]
【実施例】次にこの発明のいくつかの実施例を列挙す
る。 例1:新鮮な脱脂乳から、常法(pH4.5に調整しカ
ゼインを遠心分離で除去する)により得た乳清(21)
のNaCl濃度を1.0Mにした。1.0MNaCl溶
液で平衡化してあるブチルトヨパ−ル等の疎水クロマト
グラフィ−樹脂300mlをNaCl濃度1.0Mにし
た乳清(21)と混合し、室温下で20〜30分間ゆつ
くりと攪拌した。これを濾紙又はガラスウ−ル濾過膜で
濾過し、280nmの吸収が検出できなくなるまで1.
0M NaCl溶液(約1.51)で洗浄した。次に1
1の40%(V/V)エタノ−ルで全物質を溶出させ
た。ブチトヨパ−ル非吸着画分を分画分子量6K〜14
Kの限外濾過モジユ−ル(旭化成社製)を用いて脱塩
し、高純度のβ−Lg9.4gを得た(図1)。また4
0%(V/V)エタノ−ルで溶出した画分のエタノ−ル
を減圧下で除去し、分画分子量50Kの限外濾過モジュ
−ル(旭化成社製)を用いて分別し、濾過液と非濾過液
をそれぞれ集め、分画分子量6Kの限外濾過モジュ−ル
(旭化成社製)で脱塩、濃縮した後、凍結乾燥又は噴霧
乾燥法により、高純度のα−La2.5g(図2)と、
粗Lf(Lf含量約30%)1.1g(図3)を得た。EXAMPLES Some examples of the present invention will be listed below. Example 1: Whey (21) obtained from fresh skim milk by a conventional method (adjusting to pH 4.5 and removing casein by centrifugation)
NaCl concentration of 1.0M. 300 ml of a hydrophobic chromatography resin such as butyltoyopar equilibrated with a 1.0 M NaCl solution was mixed with whey (21) having a NaCl concentration of 1.0 M, and the mixture was gently stirred at room temperature for 20 to 30 minutes. This was filtered through a filter paper or a glass wool filter membrane, and 1. until absorption at 280 nm could not be detected.
Wash with 0M NaCl solution (ca. 1.51). Then 1
All material was eluted with 1 40% (V / V) ethanol. Butytoyopar non-adsorbed fraction was fractionated with a molecular weight of 6K to 14
It was desalted using K ultrafiltration module (manufactured by Asahi Kasei Co., Ltd.) to obtain 9.4 g of highly pure β-Lg (FIG. 1). Again 4
The ethanol fraction of the fraction eluted with 0% (V / V) ethanol was removed under reduced pressure, and the mixture was fractionated using an ultrafiltration module (Asahi Kasei Co., Ltd.) having a molecular weight cutoff of 50K, and the filtrate was obtained. And non-filtrate were respectively collected, desalted and concentrated with an ultrafiltration module (made by Asahi Kasei Co., Ltd.) having a molecular weight cut off of 6K, and then 2.5 g of highly pure α-La (Fig. 2) and
1.1 g of crude Lf (Lf content about 30%) (FIG. 3) was obtained.
【0010】例2:遠心分離法により調製した清澄化ゴ
−ダタイプチ−ズホエ−(協同乳業社製)11にNaC
lを1.0Mになるように添加し、1.0M NaCl
溶液で平衡化してある疎水クロマトグラフィ−樹脂(ブ
チルトヨパ−ル、ト−ソ−社製)150mlと混合し、
室温下で20〜30分間ゆつくり攪拌した。以下の操作
は前記例1に準じて行ない、高純度のβ−Lg4.7g
(図1)、α−La2.1g(図2)及び粗Lf(Lf
含量約30%)1.9g(図3)を得た。Example 2: Clarified Godatype Cheesehoe (made by Kyodo Dairy Co.) 11 prepared by centrifugation and NaC
l was added to 1.0 M, and 1.0 M NaCl was added.
Mix with 150 ml of a hydrophobic chromatography resin (butyl toyopar, manufactured by Tosoh Corporation) equilibrated with the solution,
The mixture was gently stirred at room temperature for 20 to 30 minutes. The following operation was performed according to the above-mentioned Example 1, and high-purity β-Lg 4.7 g
(FIG. 1), α-La2.1g (FIG. 2) and coarse Lf (Lf
1.9 g (FIG. 3) was obtained with a content of about 30%.
【0011】例3:限外濾過法により約10倍に濃縮し
た酸ホエ−蛋白質(協同乳業社製)11のpHを6N
HClで3.0に調整し、NaCl溶液で平衡化した疎
水クロマトグラフィ−樹脂(ブチルトヨパ−ル、ト−ソ
−社製)1.51と混合した。室温下で20〜30分間
ゆつくり攪拌し濾過した。280nmの吸収を検出でき
なくなるまでpH3.0にHClで調整した0.75M
NaClで樹脂を洗浄した後、樹脂に吸着した蛋白質
をおなじpHに調整した0.5M NaClで溶出させ
た。次に40%(V/V)エタノ−ルですべての吸着物
を溶出させ、それぞれ前記例1に記載した操作法に準じ
て行ない、高純度のβ−Lg45.2g、α−La8.
5g及び粗Lf5.5gを得た。Example 3: Acid whey protein (manufactured by Kyodo Dairy Co., Ltd.) 11 concentrated to a concentration of about 10 times by the ultrafiltration method was adjusted to pH 6N
The mixture was adjusted to 3.0 with HCl and mixed with 1.51 of a hydrophobic chromatography resin (Butyl Toyopar, Toso Co.) equilibrated with a NaCl solution. The mixture was stirred at room temperature for 20 to 30 minutes, stirred and filtered. 0.75 M adjusted to pH 3.0 with HCl until no absorption at 280 nm can be detected
After washing the resin with NaCl, the protein adsorbed on the resin was eluted with 0.5 M NaCl adjusted to the same pH. Next, all adsorbed substances were eluted with 40% (V / V) ethanol, and each was carried out according to the operation method described in the above Example 1, and highly pure β-Lg 45.2 g, α-La8.
5 g and crude Lf 5.5 g were obtained.
【0012】例4:前記例1で得た乳清(21)のpH
を1N HClでpH3.0に調整し、0.5Mになる
ようにNaClを添加した。pHを3.0に調整した
0.5M NaClで平衡化した疎水クロマトグラフィ
−樹脂(ブチルトヨパ−ル、ト−ソ−社製)150ml
に加え、室温下で20〜30分間ゆつくりと攪拌した。
その後の操作は前記例3に記載の方法に準じて行ない、
高純度のβ−Lg9.5g、α−La2.1g及び粗L
f1.1gを得た。Example 4: pH of the whey (21) obtained in Example 1 above
Was adjusted to pH 3.0 with 1N HCl, and NaCl was added to 0.5M. 150 ml of hydrophobic chromatography resin (Butyl Toyopar, Toso Co.) equilibrated with 0.5 M NaCl whose pH was adjusted to 3.0
In addition, the mixture was gently stirred at room temperature for 20 to 30 minutes.
Subsequent operations are performed according to the method described in Example 3,
High-purity β-Lg 9.5 g, α-La 2.1 g and crude L
f1.1g was obtained.
【0013】例5:限外濾過法で約10倍に濃縮したゴ
−ダタイプチ−ズホエ−(協同乳業社製)11を前記例
3に記載の方法に準じて処理した。高純度のβ−Lgと
α−Laをそれぞれ38.2gと5.5g及び粗Lf
5.1gを得た。Example 5 Godatype cheesehoe (manufactured by Kyodo Daigaku Co., Ltd.) 11 concentrated about 10 times by the ultrafiltration method was treated according to the method described in Example 3 above. 38.2 g and 5.5 g of high-purity β-Lg and α-La, respectively, and crude Lf
5.1 g was obtained.
【0014】[0014]
【発明の効果】この発明の方法は、ホエ−からβ−L
g、α−La及びLfを一連の操作工程で効率的に生産
するために、各蛋白質の疎水性の差異を利用したもので
あつて、たとえば前出のチアンコネとガツトニ(特開昭
64−63598号公報)が報告しているようなβ−L
gを固定化したバイオアフィニティ−クロマトグラム法
を用いれば、特異的にβ−Lgを得ることができること
は周知の事実である。しかしこのような方法は、出発材
料を高度に前処理(清澄化及び脱塩等)しなければなら
ず、固定化担体自体非常に高価である。そればかりでな
く、固定化β−Lg自体微生物汚染に弱く、耐酸性、耐
塩基性、耐圧性等に欠け、長期間の使用は不可能であ
る。しかし本発明者らが使用した疎水クロマトグラフィ
−樹脂の官能基は、化学的なブチル基やフェニル基等で
あり、耐酸性、耐塩基性、耐圧性、耐微生物性に優れ、
室温下でも使用できることから、工業的規模での利用が
可能になり、従来非常に高価な食品素材とされてきたβ
−Lg、α−La及びLfの価格を大幅に低減すること
が可能となる。Industrial Applicability The method of the present invention comprises whey-β-L.
In order to efficiently produce g, .alpha.-La and Lf through a series of operating steps, the difference in hydrophobicity of each protein is utilized. For example, the above-mentioned Tiancone and Gattoni (Japanese Patent Laid-Open No. 64-63598). Β-L as reported by
It is a well-known fact that β-Lg can be specifically obtained by using the bioaffinity chromatogram method in which g is immobilized. However, such a method requires a high degree of pretreatment of the starting material (such as clarification and desalting), and the immobilization carrier itself is very expensive. In addition, the immobilized β-Lg itself is vulnerable to microbial contamination, lacks acid resistance, base resistance, pressure resistance, etc., and cannot be used for a long period of time. However, the functional group of the hydrophobic chromatography-resin used by the present inventors is a chemical butyl group, a phenyl group, etc., and is excellent in acid resistance, base resistance, pressure resistance, microbial resistance,
Since it can be used even at room temperature, it can be used on an industrial scale, and β has been regarded as a very expensive food material in the past.
It is possible to significantly reduce the prices of -Lg, α-La and Lf.
【図1】ブチトヨパ−ル非吸着画分を分画分子量6K〜
14Kの限外濾過モジユ−ルを用いて脱塩して得られた
β−Lgを示す。FIG. 1 shows a molecular weight cut-off of 6K for butytoyopar non-adsorbed fraction.
The β-Lg obtained by desalting with an ultrafiltration module of 14K is shown.
【図2】40%(V/V)エタノ−ルで溶出した画分の
エタノ−ルを減圧下で除去し分画分子量50Kの限外濾
過モジユ−ルを用いて分別し、濾過液と非濾過液を、分
画分子量6Kの限外濾過モジユ−ルで脱塩、濃縮した
後、乾燥して得たα−Laを示す。[Fig. 2] Ethanol of a fraction eluted with 40% (V / V) ethanol was removed under reduced pressure, and fractionation was performed using an ultrafiltration module having a molecular weight cutoff of 50K, and the fraction was separated from the filtrate. The α-La obtained by desalting and concentrating the filtrate with an ultrafiltration module having a molecular weight cut off of 6K and then drying is shown.
【図3】上記方法により得た粗Lfを示す。FIG. 3 shows rough Lf obtained by the above method.
1 β−Lg(例1) 2 β−Lg(例2) 3 α−La(例1) 4 α−La(例2) 5 粗Lf(例1) 6 粗Lf(例2) M 分子量マ−カ− 1 β-Lg (Example 1) 2 β-Lg (Example 2) 3 α-La (Example 1) 4 α-La (Example 2) 5 Crude Lf (Example 1) 6 Crude Lf (Example 2) M Molecular weight marker Car
Claims (3)
質濃度0.5〜10%、NaCl濃度1.0Mに調整し
て、疎水クロマトグラフィ−樹脂に接触させ、0.75
M NaCl及び40%(V/V)エタノ−ルで分画す
ることを特徴とする牛乳ホエ−由来β−ラクトグロブリ
ン、α−ラクトアルブミン及びラクトフェリンの製造
法。1. Milk whey is adjusted to pH 4.4 to 4.6, protein concentration 0.5 to 10%, NaCl concentration 1.0 M, and brought into contact with a hydrophobic chromatography resin to obtain 0.75.
A method for producing β-lactoglobulin, α-lactalbumin and lactoferrin derived from milk whey, which comprises fractionating with M NaCl and 40% (V / V) ethanol.
0.5〜10%、NaCl濃度0.5Mに調整して、疎
水クロマトグラフィ−樹脂に接触させ、0.75M N
aCl及び40%(V/V)エタノ−ルで分画すること
を特徴とする牛乳ホエ−由来β−ラクトグロブリン、α
−ラクトアルブミン及びラクトフェリンの製造法。2. Milk whey is adjusted to pH 3.0, protein concentration 0.5 to 10%, NaCl concentration 0.5M, and brought into contact with a hydrophobic chromatography resin to obtain 0.75M N
Milk whey-derived β-lactoglobulin, α, characterized by fractionation with aCl and 40% (V / V) ethanol
-A method for producing lactalbumin and lactoferrin.
それらの濃縮等の加工されたホエ−から選ばれた一種又
はそれ以上である請求項1又は2記載の牛乳由来β−ラ
クトグロブリン、α−ラクトアルブミン及びラクトフェ
リンの製造法。3. The milk-derived β-lacto according to claim 1 or 2, wherein the milk whey is one or more selected from acid whey, sweet whey and processed whey such as concentrated whey. A method for producing globulin, α-lactalbumin and lactoferrin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1496494A JPH07203863A (en) | 1994-01-14 | 1994-01-14 | Method for producing milk whey-derived β-lactoglobulin, α-lactalbumin and lactoferrin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1496494A JPH07203863A (en) | 1994-01-14 | 1994-01-14 | Method for producing milk whey-derived β-lactoglobulin, α-lactalbumin and lactoferrin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07203863A true JPH07203863A (en) | 1995-08-08 |
Family
ID=11875667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1496494A Pending JPH07203863A (en) | 1994-01-14 | 1994-01-14 | Method for producing milk whey-derived β-lactoglobulin, α-lactalbumin and lactoferrin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07203863A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU708761B2 (en) * | 1996-01-26 | 1999-08-12 | Massey University | Method of separating and recovering proteins from a protein solution |
WO2001007077A1 (en) * | 1999-07-28 | 2001-02-01 | Morinaga Milk Industry Co., Ltd. | Antiulcer agents |
WO2007032459A1 (en) | 2005-09-16 | 2007-03-22 | Meiji Dairies Corporation | Method of improving the texture of fermented milk |
-
1994
- 1994-01-14 JP JP1496494A patent/JPH07203863A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU708761B2 (en) * | 1996-01-26 | 1999-08-12 | Massey University | Method of separating and recovering proteins from a protein solution |
US6528622B1 (en) | 1996-01-26 | 2003-03-04 | Massey University | Method of separating and recovering proteins from a protein solution |
WO2001007077A1 (en) * | 1999-07-28 | 2001-02-01 | Morinaga Milk Industry Co., Ltd. | Antiulcer agents |
US6815419B1 (en) | 1999-07-28 | 2004-11-09 | Morinaga Milk Industry Co., Ltd. | Antiulcer agent |
WO2007032459A1 (en) | 2005-09-16 | 2007-03-22 | Meiji Dairies Corporation | Method of improving the texture of fermented milk |
EP2394515A1 (en) | 2005-09-16 | 2011-12-14 | Meiji Dairies Corporation | Method of Improving the Texture of Fermented Milk |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Atamer et al. | Bovine β-casein: Isolation, properties and functionality. A review | |
EP2681230B1 (en) | Method for isolating osteopontin using feeds containing caseino macropeptide (cmp) | |
US5986063A (en) | Isolating β-lactoglobulin and α-lactalbumin by eluting from a cation exchanger without sodium chloride | |
US5968586A (en) | Production of κ-casein macropeptide for nutraceutical uses | |
US5436020A (en) | Method for producing a formulated milk for infants analogous to human milk | |
US5077067A (en) | Process for the selective and quantitative elimination of lactoglobulins from a starting material containing whey proteins | |
US5194591A (en) | Isolation of an immunoglobulin rich fracton from whey | |
US20030026845A1 (en) | Process for preparing protein isolate from milk, whey, colostrum, and the like | |
JPH0131865B2 (en) | ||
Pearce | Whey protein recovery and whey protein fractionation | |
US6555659B1 (en) | Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w | |
JP2961625B2 (en) | Method for producing a composition having a high content of α-lactalbumin | |
EP0443763B1 (en) | Formulated milk for infants analogous to human milk | |
JPH07203863A (en) | Method for producing milk whey-derived β-lactoglobulin, α-lactalbumin and lactoferrin | |
US6592905B1 (en) | Production of an immunoglobulin enriched fraction from whey protein solutions | |
WO1999018808A1 (en) | Production of kappa-casein macropeptide | |
JP3759984B2 (en) | Purification of component 3 of milk proteose peptone | |
JP3225080B2 (en) | Method for producing a composition having a high content of kappa-casein glycomacropeptide | |
NZ243727A (en) | Isolation of charged particles from fluids by ion exchange where the ion exchange medium is disposed on a porous membrane | |
US5436014A (en) | Removing lipids from cheese whey using chitosan | |
JP3044487B2 (en) | Method for producing a composition containing sialic acids and having a high α-lactalbumin content | |
JP3347819B2 (en) | Purification method of antimicrobial peptide | |
JP3225081B2 (en) | Method for producing a composition having a high content of kappa-casein glycomacropeptide | |
EP0980212A1 (en) | A substantially insulin-free protein composition, preparation and use thereof, and products containing same and preparation thereof | |
US20020183489A1 (en) | Large scale production of low fat and SDS gel pure kappa-casein glycomacropeptides (GMP) from bovine deproteinzed whey |